Comparison of NITAG policies and working processes in selected developed countries

Highlights • NITAG recommendation is critical for vaccine market access. • Comparison of NITAG policies was performed in 13 selected developed countries. • Vaccine processes are heterogeneous, less structured, less transparent than HTA for other drugs. • There is a need for improving the decision fr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2015-01, Vol.33 (1), p.3-11
Hauptverfasser:	Ricciardi, G.W, Toumi, M, Weil-Olivier, C, Ruitenberg, E.J, Dankó, D, Duru, G, Picazo, J, Zöllner, Y, Poland, G, Drummond, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology Australia Communicable Diseases - epidemiology Decision making Decision-making process Developed Countries Europe Experts Framework Health Policy Humans Immunization Literature reviews Meetings National Immunization Technical Advisory Group North America Public health Studies Terms of reference Vaccination - methods Vaccination - utilization Vaccine Vaccines Vaccines - administration & dosage Vaccines - immunology Websites
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • NITAG recommendation is critical for vaccine market access. • Comparison of NITAG policies was performed in 13 selected developed countries. • Vaccine processes are heterogeneous, less structured, less transparent than HTA for other drugs. • There is a need for improving the decision framework for NITAG recommendations.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2014.09.023